HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Evan Y Yu Selected Research
Evan Y Yu Research Topics
Disease
84
Prostatic Neoplasms (Prostate Cancer)
05/2024 - 05/2003
61
Neoplasms (Cancer)
05/2024 - 07/2003
44
Carcinoma (Carcinomatosis)
12/2023 - 12/2009
29
Urinary Bladder Neoplasms (Bladder Cancer)
04/2024 - 01/2013
24
Neoplasm Metastasis (Metastasis)
10/2023 - 01/2011
14
Disease Progression
11/2023 - 01/2011
5
Fatigue
01/2022 - 04/2010
4
Pain (Aches)
01/2022 - 09/2014
4
Circulating Neoplastic Cells
02/2018 - 04/2013
3
Exanthema (Rash)
11/2023 - 02/2012
3
Microsatellite Instability
01/2023 - 01/2020
3
Sepsis (Septicemia)
01/2022 - 11/2017
3
Urologic Neoplasms (Urological Cancer)
01/2022 - 10/2019
2
Margins of Excision
01/2023 - 01/2020
2
Turcot syndrome
01/2023 - 01/2020
2
Hot Flashes
12/2020 - 02/2015
2
Adenocarcinoma
10/2019 - 01/2019
2
Venous Thromboembolism
01/2019 - 10/2017
2
Lymphatic Metastasis
01/2019 - 09/2010
2
Fever (Fevers)
07/2016 - 09/2010
2
Bone Diseases (Bone Disease)
04/2010 - 12/2009
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
09/2023
1
Fowlpox
03/2023
1
Vaccinia
03/2023
Drug/Important Bio-Agent (IBA)
23
Androgens
IBA
04/2024 - 06/2010
20
Cisplatin (Platino)
FDA Link
Generic
10/2023 - 01/2013
19
Platinum
IBA
10/2023 - 02/2012
17
Immune Checkpoint Inhibitors
IBA
12/2022 - 12/2016
12
Hormones (Hormone)
IBA
01/2023 - 05/2003
12
Docetaxel (Taxotere)
FDA Link
01/2022 - 09/2010
12
Prostate-Specific Antigen (Semenogelase)
IBA
01/2020 - 05/2003
10
Androgen Receptors (Androgen Receptor)
IBA
11/2023 - 04/2010
9
Biomarkers (Surrogate Marker)
IBA
04/2024 - 03/2015
9
enzalutamide
IBA
11/2023 - 04/2010
8
pembrolizumab
IBA
11/2023 - 01/2021
7
abiraterone
IBA
11/2023 - 01/2013
7
Gemcitabine
FDA Link
01/2023 - 01/2013
6
enfortumab vedotin
IBA
12/2023 - 10/2019
6
Prednisone (Sone)
FDA Link
Generic
01/2022 - 09/2010
5
Antigens
IBA
05/2024 - 12/2021
5
Testosterone (Sustanon)
FDA Link
01/2023 - 07/2013
5
sipuleucel-T (APC8015)
FDA Link
12/2021 - 05/2015
5
Dasatinib (BMS 354825)
FDA Link
01/2021 - 12/2009
4
Proteins (Proteins, Gene)
FDA Link
05/2024 - 01/2021
4
Immunoconjugates (Immunoconjugate)
IBA
12/2023 - 10/2019
4
Abiraterone Acetate
IBA
11/2023 - 01/2013
4
olaparib
IBA
03/2023 - 01/2023
4
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2022 - 01/2020
4
Ramucirumab
IBA
01/2022 - 01/2016
4
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 10/2016
3
Carboplatin (JM8)
FDA Link
Generic
11/2022 - 01/2021
3
Circulating Tumor DNA
IBA
06/2021 - 01/2019
3
Cell-Free Nucleic Acids
IBA
06/2021 - 01/2019
3
B7-H1 Antigen
IBA
01/2021 - 01/2017
3
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
01/2020 - 01/2016
3
cixutumumab
IBA
01/2020 - 05/2015
3
Radium-223
IBA
01/2018 - 01/2017
3
Vinblastine (Vinblastine Sulfate)
FDA Link
08/2015 - 01/2013
3
Methotrexate (Mexate)
FDA Link
Generic
08/2015 - 01/2013
3
Doxorubicin (Adriamycin)
FDA Link
Generic
08/2015 - 01/2013
3
Leuprolide (Lupron)
FDA Link
Generic
02/2015 - 06/2010
3
src-Family Kinases
IBA
12/2013 - 12/2009
2
Membrane Proteins (Integral Membrane Proteins)
IBA
05/2024 - 12/2023
2
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
04/2024 - 05/2015
2
sacituzumab govitecan
IBA
12/2023 - 12/2021
2
ErbB Receptors (EGF Receptor)
IBA
09/2023 - 09/2014
2
atezolizumab
IBA
03/2023 - 01/2017
2
Phenobarbital (Luminal)
FDA Link
01/2023 - 12/2019
2
taxane
IBA
01/2022 - 01/2020
2
Estrogen Receptor alpha
IBA
12/2020 - 02/2015
2
3- fluoro- N- (4- fluorophenyl)- 4- hydroxy- N- (4- hydroxyphenyl)benzamide
IBA
12/2020 - 02/2015
2
Estrogens (Estrogen)
FDA Link
12/2020 - 02/2015
2
Therapeutic Uses
IBA
10/2019 - 01/2017
2
RNA (Ribonucleic Acid)
IBA
01/2019 - 04/2016
2
MicroRNAs (MicroRNA)
IBA
02/2018 - 10/2014
2
Niclosamide
FDA Link
01/2018 - 01/2018
2
Alkaline Phosphatase
IBA
01/2017 - 04/2013
2
Paraffin
IBA
12/2016 - 10/2016
2
Formaldehyde (Formol)
FDA Link
12/2016 - 10/2016
2
Flutamide (Eulexin)
FDA Link
Generic
02/2015 - 06/2010
2
Complement System Proteins (Complement)
IBA
11/2012 - 03/2005
1
177Lu-PSMA-617
IBA
04/2024
1
avelumab
IBA
10/2023
1
Trastuzumab (Herceptin)
FDA Link
09/2023
1
tucatinib
IBA
09/2023
1
CD58 Antigens (LFA-3)
IBA
03/2023
1
Combined Vaccines
IBA
03/2023
Therapy/Procedure
62
Castration
05/2024 - 12/2009
57
Therapeutics
04/2024 - 05/2003
41
Drug Therapy (Chemotherapy)
10/2023 - 05/2003
26
Cystectomy
04/2024 - 01/2013
21
Neoadjuvant Therapy
10/2023 - 05/2003
7
Immunotherapy
01/2021 - 05/2015
5
Adjuvant Chemotherapy
04/2024 - 01/2018
5
Radiotherapy
11/2022 - 01/2011
4
Prostatectomy (Retropubic Prostatectomy)
07/2018 - 06/2010
3
Precision Medicine
12/2021 - 05/2015
2
Combination Drug Therapy (Combination Chemotherapy)
12/2021 - 10/2019
2
Chemoradiotherapy
04/2018 - 10/2016
2
Aftercare (After-Treatment)
03/2015 - 12/2009